THE NIGHTINGALE CLINIC LIMITED

Company Registration Number:
09336480 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2023

Period of accounts

Start date: 01 January 2023

End date: 31 December 2023

THE NIGHTINGALE CLINIC LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2023

Balance sheet
Notes

THE NIGHTINGALE CLINIC LIMITED

Balance sheet

As at 31 December 2023


Notes

2023

2022


£

£
Fixed assets
Intangible assets: 3 14,250 19,950
Tangible assets: 4 15,050 19,150
Total fixed assets: 29,300 39,100
Current assets
Stocks: 5,000 5,000
Debtors:   3,163 3,163
Cash at bank and in hand: 102,866 95,474
Total current assets: 111,029 103,637
Creditors: amounts falling due within one year:   (20,717) (17,053)
Net current assets (liabilities): 90,312 86,584
Total assets less current liabilities: 119,612 125,684
Provision for liabilities: (2,277) (2,928)
Total net assets (liabilities): 117,335 122,756
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 117,334 122,755
Shareholders funds: 117,335 122,756

The notes form part of these financial statements

THE NIGHTINGALE CLINIC LIMITED

Balance sheet statements

For the year ending 31 December 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 15 August 2024
and signed on behalf of the board by:

Name: S Berman
Status: Director

The notes form part of these financial statements

THE NIGHTINGALE CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

THE NIGHTINGALE CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

2. Employees

2023 2022
Average number of employees during the period 2 2

THE NIGHTINGALE CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

3. Intangible Assets

Total
Cost £
At 01 January 2023 28,500
At 31 December 2023 28,500
Amortisation
At 01 January 2023 8,550
Charge for year 5,700
At 31 December 2023 14,250
Net book value
At 31 December 2023 14,250
At 31 December 2022 19,950

THE NIGHTINGALE CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

4. Tangible Assets

Total
Cost £
At 01 January 2023 56,000
Additions 2,527
At 31 December 2023 58,527
Depreciation
At 01 January 2023 36,850
Charge for year 6,627
At 31 December 2023 43,477
Net book value
At 31 December 2023 15,050
At 31 December 2022 19,150